[1] 王前,李涛,杜昕,等.2015—2019年全国肺结核报告发病情况分析.中国防痨杂志,2021,43(2):107-112. [2] 余卫业,谭卫国,罗一婷,等.2018 WHO全球结核报告:全球与中国关键数据分析.新发传染病电子杂志,2018,3(4):228-233. [3] Kelly A,Younus A,Lekgwara P.Minimally invasive spinal surgery in spinal tuberculosis-A case report series.Interdisciplinary Neurosurgery:Advanced Techniques and Case Management,2021,23:101010. [4] Kohno N,Akiyama M,Kyoizumi S,et al.Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies,KL-3 and KL-6,against lung adenocarcinoma.Jpn J Clin Oncol,1988,18:203-216. [5] Kishaba T,Shimaoka Y,Fukuyama H,et al.A cohort study of mortality predictors and characteristics of patients with combined pulmonary fi brosis and emphysema.BMJ Open,2012,2:e000988. [6] Yokoyama A,Kondo K,Nakajima M,et al.Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis.Respirology,2006,11:164-168. [7] 沈月霖. 肺结核病患者血清KL-6、SP-D值检测的临床意义.国外医学呼吸分册,2000,59(3):198-202. [8] 印薇薇,胡小芳,张艳.血清白细胞介素-34、巨噬细胞移动抑制因子、骨桥蛋白、超敏C反应蛋白在活动性肺结核的诊断及预后评估价值.中国呼吸与危重监护杂志,2023,22(12):868-872. [9] 何卫芬,孙岳琴,徐红.血清HBD-2与OPN和IL-15对老年肺结核患者预后的预测价值.中华医院感染学杂志,2021,31(10):1502-1506 [10] 樊梅,王宋平.骨桥蛋白与肺部疾病关系的研究进展.中国呼吸与危重监护杂志,2017,16(5):525-528. [11] 高艳虹,王洪复.骨桥蛋白与骨代谢.中国骨质疏松杂志,2001,7(3):277-282. |